newheader.jpg
 

Conference Menu

Overview
Pre-Conference Workshops
Genomic Biomarkers
Protein Biomarkers
Metabolic Biomarkers
Toxicity Biomarkers
Register
Download PDF
Hotel & Travel
Sponsor & Exhbit
Press Pass
Request Brochure
Send to a Colleague
 

Corporate Sponsor:

 

Corporate Support:

 
Lead Sponsoring Publications:
 
Sponsoring Publications:
 
Web Partners:

Register by August 10th and Save up to  $200!

Conference Summary

WORKSHOP: Biomarker Assay Development and Validation

WORKSHOP: microRNA as Cancer Biomarkers 

Main Conference

Third Annual Genomic Biomarkers

Fifth Annual Protein Biomarkers

Eighth Annual Metabolic Biomarkers

Third Annual Toxicity Biomarkers

Coverage includes:

  • Systems Biology in Biomarker Discovery
  • Pharmacogenetics
  • Biomarker Validation
  • Biomarkers in Clinical Trials
  • Protein Biomarker Discovery
  • Biomarker Data Analysis
  • Toxicity Biomarker Discovery
  • Metabolomics
  • Cancer Biomarkers

Distinguished Faculty:

John L. Allinson, FIBMS, Director, Veeda Clinical Research Ltd.

Carrie Brodmerkel, Ph.D., Assistant Director, Clinical Pharmacology and Experimental Medicine, Centocor R&D 

George Calin, Ph.D., Assistant Professor, Molecular Virology, Immunology and Molecular Genetics, Ohio State University

Mark Chance, Ph.D., Director, Center for Proteomics, Case Western Reserve University

Jinzhi Chen, Ph.D., Head, Genetics/Genomics, Proteomics/Biomarker Discovery, Roche Palo Alto

Frances Clemo, DVM, Ph.D., Research Fellow, Drug Safety Research & Development, Pfizer Inc.

Dalia Cohen, Ph.D., Executive Vice President, Head, Research and Development, Rosetta Genomics

Viswanath Devanarayan, Ph.D., Director, Statistics, Biomarker Research, Abbott Laboratories

Darius Dziuda, Ph.D., Assistant Professor, Mathematics, Central Connecticut State University

Giora Feuerstein, M.D., Assistant Vice President, Head, Discovery Translational Medicine, Wyeth Research

Stephen Furlong, Ph.D., Director, Discovery Medicine, AstraZeneca

Neil Gibson, Ph.D., Research and Development Genetics, AstraZeneca

Michael Hamilton, M.D., Chief Medical Officer, Avalon Pharmaceuticals

William Hancock, Ph.D., Bradstreet Chair, Barnett Institute, and Department of Chemistry and Chemical Biology, Northeastern University

Alan Higgins, Ph.D, Senior Director, Translational Medicine, Cogenics, Inc., a division of Clinical Data Inc.

Irena Ivanovska, Ph.D., Senior Research Biologist, Rosetta Inpharmatics, A wholly owned subsidiary of Merck & Co., Inc.

Sunil Kadam, Ph.D, Research Advisor, Genomic Medicine, Eli Lilly and Co.

Rima Kaddurah-Daouk, Ph.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center

Jill M. Kolesar, Pharm.D., Associate Professor, Pharmacy, University of Wisconsin-Madison

Emmanuel Labourier, Ph.D., Director of Development, Asuragen Inc.

Jae K. Lee, Ph.D., Associate Professor, Biostatistics, University of Virginia School of Medicine; and Director, UVA Bioinformatics Support Core

Jean Lee, Ph.D., Scientific Director, PKDM, Amgen Inc.

Richard A. Lempicki, Ph.D., LIB Lab Head, Senior Scientist, Clinical Services Program, Laboratory of Immunopathogenesis and Bioinformatics, SAIC-Frederick, Inc.

Brian Luke, Ph.D., Senior Scientist, Advanced Biomedical Computing Center, National Cancer Institute

William B. Mattes, Ph.D., Director, Toxicology, The Critical Path Institute

Søren Møller, Ph.D., Chief Scientific Officer, Vice President, R&D, Exiqon A/S

Stephen Naylor, Ph.D., Chairman and Chief Executive Officer, Predictive Physiology and Medicine Inc.

Eustache Paramithiotis, Ph.D, Director, Molecular and Cellular Biology, Caprion Pharmaceuticals

Emanuel F. Petricoin, Ph.D., Co-Director, Center for Applied Proteomics and Molecular Medicine; and Professor of Life Sciences, George Mason University

Reena Philip, Ph.D., Scientific Reviewer, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration

J. Suso Platero, Ph.D., Group Leader, Clinical Biomarker Development, Bristol-Myers Squibb

Daniel Raftery, Ph.D., Professor, Chemistry, Purdue University 

Koustubh Ranade, Ph.D., Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company 

Laura K. Schnackenberg, Ph.D., Staff Fellow, Division of Systems Toxicology, National Center for Toxicological Research, Food and Drug Administration

Peter Schulz-Knappe, Ph.D., Chief Scientific Officer, Proteome Sciences plc

Natalie J. Serkova, Ph.D., Associate Professor, Anesthesiology and Radiology, Cancer Center MRI/MRS Core, University of Colorado Health Sciences Center

Vladimir Shulaev, Ph.D., Associate Professor, Virginia Bioinformatics Institute

John J. Sninsky, Ph.D., Vice President, Discovery Research, Celera Diagnostics

Vladimir Tolstikov, Ph.D., Director, Metabolomics Core, University of California, Davis Genome Center

Weida Tong, Ph.D., Director, Center for Toxicoinformatics, National Center for Toxicological Research, FDA

Kevin Wang, Ph.D., Associate Director, Center for Traumatic Brain Injury Studies (CTBIS); Director, Center for Neuroproteomics and Biomarkers Research (CNBR); and Associate Professor of Psychiatry and Neuroscience, Department of Psychiatry, McKnight Brain Institute, University of Florida

Mu Wang, Ph.D., Assistant Professor, Biochemistry and Molecular Biology and Adjunct Assistant Professor, Informatics, Indiana University School of Medicine; and Director, Protein Analysis Research Center, The Indiana Centers for Applied Protein Sciences (INCAPS)

Hans Winkler, Ph.D., Senior Director, Functional Genomics, Johnson and Johnson Pharmaceutical R&D 

Qiuwei Xu, Ph.D., Merck Research Laboratories

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com